Improving COVID-19 Vaccine Uptake Among Racial and Ethnic Minority Groups with Rheumatic Diseases
Status: Recruiting
Location: See all (3) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The overall goal of this study is to determine whether a novel, multi-modal, patient-directed behavioral intervention initiated in rheumatology clinics is an effective approach to improve uptake of updated COVID-19 vaccine.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Adults (18+ years) with known AIRD
• Black race and/or Latinx ethnicity
• Individuals who have not obtained the updated COVID-19 vaccine series (self-report)
Locations
United States
Alabama
University of Alabama at Birmingham
RECRUITING
Birmingham
Massachusetts
Brigham Women's Hospital
NOT_YET_RECRUITING
Boston
University of Massachusetts Chan Medical School
NOT_YET_RECRUITING
Worcester
Contact Information
Primary
Stephanie S Ford, Clinical Research Administration Manager, MS
sledbetter@uabmc.edu
2059347423
Time Frame
Start Date: 2024-12-18
Estimated Completion Date: 2027-08-31
Participants
Target number of participants: 1170
Treatments
Experimental: Storytelling video including patient narratives, brochure and patient navigation
Participants will review video with narratives on COVID-19 vaccination in patients with AIRD, receive brochure on the same topic; and interact with patient navigators.
Active_comparator: Attention Control: Oral Health video and Oral Health brochure
Participants will review video on the importance of oral health in patients with AIRD and receive brochure on the same topic.
Related Therapeutic Areas
Sponsors
Collaborators: National Institute on Minority Health and Health Disparities (NIMHD), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Leads: University of Alabama at Birmingham